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Introduction
Human colorectal cancer is a significant public health problem in
the western world. In the United States, this cancer is the third
leading cause of cancer related death and the third most prevalent
cancer worldwide. Half of all patients diagnosed with colorectal
cancer will eventually die from the disease; and less than 10% of
patients with metastatic colorectal cancer will survive more than five
years after diagnosis. The American Cancer Society estimates that
106,100 new cases of colon cancer (52,010 men and 54,090 women)
and 40,870 new cases of rectal cancer (23,580 men and 17,290 women)
were diagnosed in 2009 [1]. It has also been estimated that in the
United States colorectal cancer caused about 10% of all cancer-related
deaths during 2009 with 49,920 deaths (25,240 men and 24,680
women) [1]. Over 90% of colon cancers are adenocarcinomas de-
veloping from the glandular crypts lining the large bowel. More
interestingly, previous reports also indicated that up to 80% of all
colorectal cancer cases and deaths are attributable to diet [2] and
such cases of colorectal cancer and related deaths may be prevented
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Purpose
The pharmacological activities, notably the anticancer properties, of bioactive constituents
fromfresh American ginseng berry have not yet been well studied. In this study, we investigated
the antiproliferative effects of fresh American ginseng berry extract (AGBE) and its represen-
tative triterpenoid glycosides using the human colorectal cancer cell line SW480.
Materials and Methods
Using high performance liquid chromatography (HPLC), the contents of 8 ginsenosides in AGBE
were determined. The cell growth inhibitory effects of AGBE and three triterpenoid glycosides
(ginsenosides Rb3, Re, and Rg3) were evaluated by proliferation assay and 
3H-thymidine
incorporation assay. Cell cycle and apoptotic effects were analyzed by using flow cytometry
after staining with propidium iodide and annexin V. 
Results
HPLC analysis data showed that AGBE has a distinct ginsenoside profile. AGBE inhibited
SW480 cell growth significantly in a time-dependent (24-96 hours) and concentration-depen-
dent (0.1-1.0 mg/mL) manner. Ginsenosides Rb3, Re, and Rg3 also possess significant anti-
proliferative activities on SW480 cells. 
3H-thymidine incorporation assay indicated that AGBE
and ginsenosides Rb3, Re, and Rg3 might inhibit the transferring and duplication of DNA in
SW480 cells. Flow cytometric assay data suggested that AGBE arrested SW480 cells in S
and G2/M phases, and significantly induced cell apoptosis. 
Conclusion
AGBE and ginsenosides Rb3, Re, and Rg3 possessed significant antiproliferative effects and
induced changes of morphological appearance on SW480 cells. The mechanisms of the
antiproliferation of AGBE and tested ginsenosides involved could be cell cycle arrest and
induction of apoptosis. 
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pISSN 1598-2998ꚢeISSN 2005-9256by dietary modifications. Although many early stage colorectal
cancers are cured by surgical resection alone, surgery is most often
combined with adjuvant radio- and chemotherapy. Radiotherapy is
often combined with one or more chemotherapeutic agents. Patients
treated for advanced staged colorectal cancer with adjuvant chemo-
therapy showed a 40% reduced risk of relapse [3,4]. On the other
hand, the great majority of studies showed that diet with adequate or
high levels of fruits and vegetables reduced risk for the disease. The
preponderance of the evidence favors the hypothesis that natural
compounds in botanicals protect against the development of colon
cancer [5,6]. Thus, there is a need to look for new herbal medicines and
evaluate their chemical compounds to protect against the develop-
ment of colon cancer, or look for complementary and alternative
medicines to treat or reduce risk of relapse. 
Asian ginseng (Panax ginseng) has been a valuable herbal medi-
cine used in Oriental countries for thousands of years [7-9]. American
ginseng (P. quinquefolius) has gained popularity with the American
public over the past decade [7,10]. Previous studies have demon-
strated that ginseng root and its major bioactive components (gin-
senosides) have complex constitutions and multifaceted pharma-
cological functions, such as anticancer properties [11,12]. The
known biochemical and pharmacological activities of ginseng include
antiaging, antidiabetic, anticarcinogenic, analgesic, antipyretic,
antistress, antifatigue, and tranquilizing properties as well as the
promotion of DNA, RNA, and protein synthesis [7,13,14]. Most of
the reports, however, have focused upon the root of ginseng for the
various functions, including anticancer activities. There is very limited
data available in the literature with regard to cancer chemopreven-
tion of fresh American ginseng berry extract (AGBE) and its triter-
penoid glycosides, commonly referred to ginsenosides [15]. Therefore,
the aim of the present study was to explore further the antipro-
liferative property of AGBE and ginsenosides, Re, Rb3, and Rg3,
the single compounds in AGBE, in human colorectal cancer cells.
Materials and Methods
1 Preparation of AGBE 
Fresh American ginseng berry was collected from a private
ginseng farm in Wausau, WI. The fresh berry was mixed with
organic solvent. After removing the seeds and the pulp, the organic
solvent was evaporated under a vacuum. Finally, the condensed
extract solution was lyophilized.
2 High performance liquid chromatography (HPLC)
analysis of AGBE 
HPLC analysis was conducted on a Waters HPLC system, with a
996 photodiode array detector (Milford, MA). The separation was
carried out on a Prodigy
TM ODS [2] column (150×4.6 mm I.D.;
Phenomenex, Torrance, CA) with a guard column (3.0×4.0 mm
I.D.; Prodigy
TM, Phenomenex). For HPLC analysis, a 20-μ L sample
was injected into the columns and eluted at room temperature with a
constant flow rate of 1.0 mL/min. Acetonitrile (solvent A) and water
(solvent B) were used. The gradient elution started with 20% solvent
A and 80% solvent B; changed to 20.3% A for 25 minutes; then
changed to 26.8% A for 3 minutes and held for 26 minutes; changed
to 35.6% A for 20 minutes; changed to 50% A for 11 minutes;
changed to 68% A for 10 minutes; changed to 95% A for 1 minute
and held for 3 minutes; changed to 20% A for 3 minutes and held
for 8 minutes. The detection wavelength was set to 202 nm. Gin-
senosides Rb1, Rc, Rd, Re, and Rg1 were purchased from Indofine
Chemical Company (Somerville, NJ); ginsenoside Rb2, Rb3, and
Rg3 were purchased from Delta Information Center for Natural
Organic Compounds (Xuancheng, China). Regression equations of
ginsenosides were prepared using standard solutions with different
concentrations.
3 Cell culture
SW480 human colorectal cells (ATCC, Manassas, VA) were
routinely grown in Leibovitz’s L-15 medium with 10% L-glutamine
(Cellgro, Herndon, VA) and supplemented with 10% fetal bovine
serum and 50 units/mL penicillin-streptomycin (Gibco, Carlsbad,
CA). Cells were maintained in a tissue culture dish (100 mm I.D.)
and kept in a humidified incubator (5% CO2 in air at 37℃) with a
medium change every 2-3 days. When the cells reached 70-80%
confluence, they were trypsinized, harvested, and seeded into a new
tissue culture dish. 
4 Cell proliferation assay 
To examine the cell growth inhibitory effect of AGBE and gin-
senosides, we conducted cell proliferative assay using cell counting
method. SW480 cells were seeded in a 24-well plate at approximately
1×10
4 cells/well with regular Leibovitz’s L-15 medium. After
adhesion for 24 hours, fresh culture medium was exchanged and then
drugs were added. Control cultures were incubated in medium con-
taining solvent vehicle alone. At the end of the drug exposure period,
the medium was removed from all wells and the cell monolayer was
washed twice with phosphate buffered saline (PBS). Cultures were
harvested and monitored for number by using a Coulter cell counter
(Coulter Electronics Inc., Hialeah, FL). In the present studies, cell
proliferative assays were performed at least three times. The
percentage of cell proliferation was calculated as follows: Cell
proliferation (%)=(cell number in each drug-treated well/average of
cell number in the control wells)×100. 
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5 Morphological observation
To observe the cell morphological changes induced by AGBE,
the SW480 cells were seeded in a 24-well plate with regular Lei-
bovitz’s L-15 medium and allowed to adhere for 24 hours. After the
SW480 cells incubated with AGBE at 1.0 mg/mL for 72 hours, the
cellular morphological changes were observed under phase contrast
microscopy (Eclipse TE2000-U, Nikon, Tokyo, Japan). Control
cultures were incubated in medium containing solvent vehicle alone.
6 3H-thymidine incorporation assay 
To explore the possible mechanism of AGBE and its ginseno-
sides’ antiproliferative properties, 
3H-thymidine incorporation assay
on SW480 cells was performed in the present experiments. The
SW480 cells were seeded in a 24-well plate and adhered for 24
hours, the cells were incubated with AGBE, or ginsenosides Rb3,
Re, and Rg3, at various concentrations with 300 μ L media containing
1 λ /mL 
3H-thymidine in each well for 72 hours. Control cultures
were incubated in medium containing solvent vehicle alone. Then,
cells were washed with PBS and 10% trichloroacetic acid and 0.5
mL NaOH (0.2 M) were added into each well and agitated for 5
minutes. Then, cells were transferred into tested vials, 5 mL of 30%
liquid scintillation were added, and radioactivity counts were
measured using Packard Tri-Carb 1500 scintillation counter (Meriden,
CT). Results are presented as the percentage of control.
7 Cell cycle and apoptosis analysis using flow cytometry
Cells were seeded in 24-well tissue culture plates. On the second
day, the medium was changed and cells were treated with AGBE.
Cells were incubated for 48 hours before they were harvested. For
the cell cycle assay, the cells were fixed gently by putting 80%
ethanol in a freezer for 2 hours and subsequently treating with
0.25% Triton X-100 for 5 minutes on ice bath. Cells were resuspended
in 300 μ L of PBS containing 40 μ g/mL propidium iodide and 0.1
mg/mL RNase. Then the cells were incubated in a dark room for 20
minutes at room temperature, and cell cycle analysis was performed.
For the apoptotic assay, cells floating in the medium were collected
after they were treated with AGBE for 48 hours. The adherent cells
were detached with trypsin. Then, culture medium containing 10%
fetal bovine serum (and floating cells) was added to inactivate trypsin,
and pipetted gently. The cells were centrifuged and then stained
with annexin V-FITC. Cells were analyzed with a FACScan flow
cytometer (Becton Dickinson, Mountain View, CA) and FlowJo
ver. 7.1.0 software (Tree Star, Ashland, OR). For each measurement
at least 10,000 cells were counted.
8 Statistical analysis
Data are expressed as mean±standard deviation. A one-way
ANOVA determined whether the results had statistical significance.
In some cases, Student’s t-test was used for comparing two groups.
The level of statistical significance was set at p＜0.05.
Results
1 HPLC of AGBE 
HPLC analysis showed that the main constituents in AGBE were
ginsenosides Rb3 (49.5 mg/g) and Re (15.1 mg/g). Other ginsenosides
contents in AGBE were ginsenosides Rb1 (1.1 mg/g), Rb2 (13.8
mg/g), Rc (5.6 mg/g), Rd (9.0 mg/g), Rg1 (0.8 mg/g), and Rg3 (0.9
mg/g). Fig. 1 shows the chromatogram of ginsenoside standards and
AGBE. The proportions of ginsenosides of AGBE were much
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Fig. 1. High performance liquid chromatographic analyses of American ginseng berry extract (AGBE). (A) Chromatogram of saponin standards,
ginsenosides Rg1, Re, Rb1, Rc, Rb2, Rb3, Rd, and Rg3. (B) Chromatogram of AGBE.different with American ginseng root extracts [16,17]. In American
ginseng root extract, the highest content of triterpenoid glycoside is
ginsenoside Rb1, while ginsenoside Rb3 is a trace triterpenoid
glycoside. However, in AGBE, ginsenoside Rb3 has the highest
content while the content of Rb1 is much lower. The specific phar-
macological effects of AGBE may have originated from the com-
position of chemical compounds, especially the ginsenosides.
2 Effects of AGBE on SW480 cells with different
treatment time 
The antiproliferative effects of AGBE on SW480 cells were
evaluated. Data showed that AGBE inhibited the growth of SW480
cells in a time-dependent manner. As shown in Fig. 2, AGBE at a
single concentration of 1.0 mg/mL decreased the viable number of
SW480 cells significantly. Compared to the vehicle control in 24,
48, 72, and 96 hours (set as 100%), the percentage of viable cells
was 89.2 at 24 hours (p＜0.05), 75.0 at 48 hours (p＜0.01), 29.0 at
72 hours (p＜0.01), and 3.2 at 96 hours (p＜0.01). It is clear that
AGBE inhibited SW480 cancer cells in a time-dependent manner.
3 Effects of AGBE on SW480 cells with different
treatment concentration 
The growth inhibitory effect of AGBE (0.1, 0.5 and 1.0 mg/mL)
against SW480 human colorectal cancer cells is shown in Fig. 3A.
After treatment for 72 hours, AGBE decreased viable cell number
significantly. The extract reduced cell growth in a concentration-
dependent manner, by 16.9% at 0.1 mg/mL (p＜0.05), 58.3% at 0.5
mg/mL (p＜0.01), and 71.0% at 1.0 mg/mL (p＜0.01), compared
with control group (normalized to 100%). The data showed inhibition
of AGBE on SW480 cancer cells in a dosage-dependent manner in
this experiment.
Morphological appearance of SW480 cells under AGBE treat-
ment for 72 hours is shown in Fig. 3B. Exposure of SW480 cells to
AGBE had a marked effect on morphology compared to the untreated
control cells. In the control group, SW480 cells showed a cobblestone-
like appearance, while the cells treated with 1.0 mg/mL of AGBE
showed an elongated fibroblastic appearance with many apoptotic
bodies. There was a remarkable increase in the number of shrunken
cells after 1.0 mg/mL of AGBE treatment. Similar but less severe
effects on cell morphological changes were observed with treatment
of AGBE in lower concentrations (0.1 and 0.5 mg/mL). These data
indicate that AGBE induces prominent changes in the morpho-
logical appearances of SW480 cancer cells.
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Fig. 2. Effects of American ginseng berry extract (AGBE) on
proliferation of SW480 cells after treatment for different time.
SW480 cells were exposed to 1.0 mg/mL of AGBE for 24, 48, 72,
and 96 hr. Control at corresponding time is normalized to 100%. *p
＜0.05, **p＜0.01 vs. corresponding control.
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Fig. 3. Effects of American ginseng berry extract (AGBE) on
proliferation and morphological changes of SW480 cells after
treatment for 72 hr. (A) SW480 cells were exposed to 0.1, 0.5 and
1.0 mg/mL of AGBE for 72 hr. Control at 72 hr is normalized to
100%. *p＜0.05, **p＜0.01 vs. control. (B) The morphological
aspects of untreated and 1 mg/mL of AGBE treated cells were
photographed with a microscope.4 Antiproliferation effects of ginsenosides Rb3, Re, and 
Rg3 on SW480 cell 
The antiproliferative effects of ginsenosides Re, Rb3, and Rg3 on
colon cancer cells SW480 were determined by cell proliferation
assay. Similar to the activities of AGBE, ginsenosides Re, Rb3, and
Rg3 significantly inhibited SW480 cell growth with a concentration-
dependent manner (Fig. 4). Re inhibited cell growth by 16.0% (0.03
mg/mL, p＜0.05), 23.0% (0.1 mg/mL, p＜0.01), and 39.0% (0.3
mg/mL, p＜0.01) compared with vehicle control (100%). The
antiproliferative effect of Rb3 is similar to Re. However, Rg3 has
inhibition that is more efficient on SW480 cell growth at 0.1 and 0.3
mg/mL. For instance, Rg3 reduced cell proliferation by 6.3% (0.03
mg/mL, p＞0.05), 47.3% (0.1 mg/mL, p＜0.01), and 94.6% (0.3
mg/mL, p＜0.01) compared with the vehicle control (100%). Data
from this study demonstrate that ginsenosides Re, Rb3, and Rg3
possess antiproliferative effects on SW480 human colorectal cancer
cells.
5 Effects of AGBE and ginsenosides on DNA synthesis
by measuring 
3H-thymidine incorporation
As shown in Fig. 5A, AGBE (0.5 and 1.0 mg/mL) significantly
suppressed cellular incorporation of 
3H-thymidine at the concen-
trations of 0.5 mg/mL (49.0%) and 1.0 mg/mL (by 78.0%, both p
＜0.01, compared with control). Similar results were obtained from
ginsenosides Re, Rb3, and Rg3 (Fig. 5B). Compared to the control
(100%), ginsenoside Rg3 suppressed 
3H-thymidine incorporation
for 26.9% at 0.03 mg/mL (p＜0.01), 61.7% at 0.1 mg/mL (p＜0.01),
and 98.2% at 0.3 mg/mL (p＜0.01). Ginsenoside Rg3 reduced the
percentage of the incorporation of cells significantly. Similar but
lower effects were obtained from Re and Rb3 (Fig. 5B). These
results suggest that ginsenosides Re, Rb3, and Rg3 are endowed
with inhibiting cellular incorporation of 
3H-thymidine, and that Rg3
possesses more positive effects on SW480 cells. 
6 Effects of AGBE on SW480 cell cycle and apoptosis 
To explore the potential mechanism through which AGBE
inhibits cell growth, cell cycle and apoptosis were assayed by flow
cytometry. As shown in Fig. 6A, compared to control (G1, 51.4%;
S, 32.3%; G2/M, 16.2%), treatment with 0.5 mg/mL of AGBE for
48 hours, 32.3% cells were in G1 phase, 42.9% cells were in S
phase, and 24.8% cells were in G2/M phase. Since the viable cells
were difficult to collect after treatment with 1 mg/mL of AGBE for
48 hours, the cell cycle profile was not obtained. Nevertheless, data
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Fig. 4. Effects of ginsenosides Rb3, Re, and Rg3 on proliferation of
SW480 cells. Cells were treated with 0.03, 0.1 and 0.3 mg/mL of
ginsenosides for 72 hr. Control at 72 hr is normalized to 100%.
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Fig. 5. Effects of American ginseng berry extract (AGBE) and ginsenosides on the 
3H-thymiding incorporation of SW480 cells. (A) SW480
cells were treated with 0.5 and 1.0 mg/mL of AGBE for 72 hr. (B) SW480 cells were treated with 0.03, 0.1, and 0.3 mg/mL of ginsenosides
Rb3, Re, and Rg3 for 72 hr. Control at 72 hr is normalized to 100%. **p＜0.01 vs. control. from this study suggested that AGBE can arrest SW480 cells in S
and G2/M phases.
The cytograms of annexin V analysis of SW480 cells after
treatment with AGBE are shown in Fig. 6B. For the control group,
the percentage of apoptotic cells was 6.5%. After treatment with 0.5
mg/mL of AGBE for 48 hours, the percentage of apoptotic cells was
increased to 24.6%. Moreover, treatment with 1 mg/mL of AGBE
increased the percentage of apoptotic cells to 40.9%. Data showed
that AGBE can induce SW480 cell apoptosis significantly. Our flow
cytometric assay results suggest that the antiproliferative effect of
AGBE could be mediated by the cell cycle arrest and the induction
of apoptosis. 
Discussion
In the developed world, human colorectal cancer is a very serious,
common disease and a significant public health problem [18,19]. It
has been pointed out that colorectal cancer is the third leading cause
of cancer death in the USA [19]. Epidemiological studies have
shown that up to 80% of colorectal cancer is attributable to diet
[2,20]. Also, a diet that contains adequate or high levels of fruits and
vegetables reduces risk of colon cancer [21]. Therefore, to prevent
and treat this disease, it is necessary to look for and identify effective
chemopreventive agents, especially from botanical resources [5].
The majority of investigations indicated that Asian ginseng root
possesses anticancer activities [11,12]. As another plant in the same
genus Panax, American ginseng root also possesses anticancer
activities [22]. Recently, the content of ginsenosides in dried American
ginseng berry was determined by HPLC, and the triterpenoid
glycoside composition was compared to American ginseng root and
leaf [16]. It has been observed that American ginseng berry has a
distinct ginsenoside profile compared to the root and leaf. Total
ginsenoside contents are different in berry, root, and leaf. The rank
in order of the total ginsenoside concentration is leaf ＞berry＞root
[16,23]. The content of ginsenoside Rb3 in the berry is much higher
than in the root. However, the triterpenoid glycoside content in fresh
AGBE was not reported. In this study, we determined the repre-
sentative ginsenoside contents in AGBE.
The purpose of the present study was to evidence the antipro-
liferative effect by which AGBE and ginsenosides Rb3, Re, and
Rg3 inhibited SW480 colorectal cancer cell growth. Our cell pro-
liferative assay test showed that AGBE (0.1-1.0 mg/mL) and gin-
senosides Rb3, Re, and Rg3 (0.03-0.3 mg/mL) inhibited the growth
of SW480 cancer cell significantly in concentration-dependent
Cancer Res Treat. 2011;43(1):49-55
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Fig. 6. Cell cycle and apoptosis analysis of SW480 cells using flow cytometry. SW480 cells were treated with 0.5 and 1.0 mg/mL of American
ginseng berry extract (AGBE) for 48 hr. (A) Cell cycle profile of SW480 cells. Since not enough viable cells were collected after treatment with 1
mg/mL of AGBE, the cell cycle profile of this group was not calculated. (B) The cytograms of apoptosis assay of SW480 cells. The percentage of
apoptotic cells was indicated. Jing-Tian Xie, et al_Fresh Ginseng Berry on Cancer
and/or time-dependent manners.
Generally, cell death may be divided into two morphologically
and biochemically distinct modes, those of apoptosis and necrosis
[11]. Apoptosis is characterized by cell shrinkage, nuclear and DNA
fragmentation, and breaking up of the cell into membrane-bounded
vesicles, termed apoptotic bodies. In our morphological observation,
shrinking cells and apoptotic bodies were observed (Fig. 3B). Our
3H-thymidine assay also showed that AGBE and ginsenosides, Re,
Rb3, and Rg3 suppressed cellular incorporation and may have
inhibited transferring and duplication of SW480 cell’s DNA.
Although the mechanism by which AGBE and ginsenosides, Re,
Rb3, and Rg3 exert their inhibitive activity on the SW480 cancer
cells is largely unknown, previous reports suggested that at least five
possible mechanisms (antioxidant effect; activation of carcinogen
metabolism; detoxification of carcinogen metabolism; anti-hormone
activity; and anti-inflammatory activity) may be involved in phyto-
chemicals providing cancer protection [11]. In this study, we carried
out cell cycle and apoptotic analyses. We found that the cell growth
inhibitory activities of AGBE are accomplished through cell cycle
arrest and apoptosis induction. Based on our preliminary results, the
inhibitory effects of the AGBE and ginsenosides Re, Rb3, and Rg3
are not due to a direct killing of the SW480 cancer cells, rather, it
may likely be through effects on the cell cycle and apoptotic changes.
On the other hand, antioxidant effects of AGBE and ginsenoside Re
have also been identified in our previous reports [24,25]. This may
play a partial role in the antiproliferation function for AGBE and its
ginsenosides on colorectal cancer cells.
Conclusion
Data from our study showed that both AGBE and ginsenosides
Rb3, Re, and Rg3 possessed significant antiproliferative effects and
induced the changes of morphological appearance on SW480 human
colorectal cancer cells. The mechanisms of the antiproliferation of
AGBE and ginsenosides involved could be cell cycle arrest and in-
duction of apoptosis. Further work is needed to identify responsible
cell cycle and apoptotic pathways that AGBE mediated cancer cell
growth inhibition. 
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